Abbott Laboratories (ABT) Stock Guide

May 23, 2020
75

Before we start: if you're looking for ABT stock price, you can quickly find it out by visiting Finny and typing "ABT quote". If you're looking for a quick scoop on ABT stock (chart, price target, market cap, news and buy or sell analysis), go to Finny and look for "ABT". You'll get all this info in one place. Or you can just type "ABT news" to get the latest stock news.

Looking to buy or sell Abbott Laboratories (ABT)? Interested in getting the full scoop on ABT, including earnings and dividends, stock forecast, buy or sell analysis and key stats? If so, you came to the right place.

In this ABT stock guide, we'll address key questions about ABT, above and beyond what you can find on Yahoo Finance, Zacks, MarketWatch or Morningstar.

Here is what you'll be able to find in this guide:

Earnings and Dividends: earnings, earnings date, dividend rate and dividend yield;
Analyst Predictions: stock forecast and analyst ratings;
Analysis: Finny Score and buy or sell analysis;
Key Stats: revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio, industry, sector, and number of employees.

And here is the list of questions we'll answer:
1. What are ABT earnings?
2. When is ABT earnings date?
3. What is ABT dividend?
4. What is ABT dividend yield?
5. What is ABT stock forecast (i.e., prediction)?
6. ABT buy or sell? What is ABT Finny Score?
7. What are the reasons to buy ABT? Why should I buy ABT stock?
8. What are the reasons to sell ABT? Why should I sell ABT stock?
9. What are ABT key stats: revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio industry, sector, and number of employees?

So let's start. Scroll down to the question that interests you the most.

Earnings and Dividends

1. What are ABT earnings?

ABT trailing 12-month earnings per share (EPS) is $1.99.

2. When is ABT earnings date?

ABT earnings date is July 15, 2020.

3. What is ABT dividend?

ABT forward dividend is $1.44.

4. What is ABT dividend yield?

ABT forward dividend yield is 1.56%.

Analyst Predictions

5. What is ABT stock forecast (i.e., prediction)?

Based on ABT analyst price targets, ABT stock forecast is $102.13 (for a year from now). That means the average analyst price target for ABT stock is $102.13. The prediction is based on 20 analyst estimates.

The low price target for ABT is $79.00, while the high price target is $113.00.

ABT analyst rating is Buy.

Analysis

6. ABT buy or sell? What is ABT Finny Score?

Our quantitative analysis shows 6 reasons to buy and 2 reasons to sell ABT, resulting in Finny Score of 75.

7. What are the reasons to buy ABT? Why should I buy ABT stock?

Here are the reasons to buy ABT stock:

  • Abbott's Xience stent remains a powerhouse in the drug-eluting stent market, thanks to its well-established record of safety and efficacy.
  • Aggressive cost-cutting plans should propel Abbott's bottom-line growth more quickly than top-line growth.
  • Abbott's sale of its established pharma business in developed markets to Mylan and its acquisition of CFR and Veropharm have put Abbott's branded generics business in a strong position to benefit from growing demand in emerging markets.
  • ABT quarterly revenue growth was 2.50%, higher than the industry and sector average revenue growth (1.93% and 1.16%, respectively). See ABT revenue growth chart.
  • ABT profitability is improving. The YoY profit margin change was 6.00 percentage points. See ABT profitability chart.
  • ABT forward dividend yield is 1.56%, higher than the industry (0.12%) and sector (0.16%) forward dividend yields. See ABT forward dividend chart.
  • ABT average analyst rating is Buy. See ABT analyst rating chart.
  • ABT average analyst price target ($102.13) is above its current price ($91.47). See ABT price target chart.
  • ABT cash to debt ratio is 0.20, higher than the average industry (0.18) and sector (0.16) cash to debt ratio. See ABT cash to debt chart.

8. What are the reasons to sell ABT? Why should I sell ABT stock?

Let's look at the reasons to sell ABT stock (i.e., the bear case):

  • Abbott faces an uphill battle in the diagnostics arena, where it must go head-to-head against market leader Roche, along with energetic upstarts like Qiagen and Hologic.
  • Considering the heterogeneity involved in mitral valve disease, we are skeptical that MitraClip will move beyond niche use for certain inoperable patients.
  • ABT forward P/E ratio is 25.01, which is high compared to its industry peers’ P/E ratios. See ABT forward P/E ratio chart.
  • ABT Price/Sales ratio is 5.06, which is high compared to its industry peers’ P/S ratios. See ABT forward Price/Sales ratio chart.

Key Stats

9. What are ABT key stats : revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio industry, sector, and number of employees?

Let's look at the key statistics for ABT:

Metrics ABT
Price $93.39
Average Price Target / Upside $102.13 / 9.36%
Average Analyst Rating Buy
Forward Dividend Yield 1.56%
Industry Medical Devices
Sector Healthcare
Number of Employees 103,000
Market Cap $162.35B
Forward P/E Ratio 25.01
Price/Book Ratio 5.06
Revenue (TTM) $32.1B
YoY Quarterly Revenue Growth 2.50%
Profit Margin 11.15%

If you liked this analysis, check out Stock Guides for other stocks.

Follow Us